PMC:7212949 / 5154-5676 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T5","span":{"begin":395,"end":399},"obj":"Body_part"},{"id":"T6","span":{"begin":428,"end":433},"obj":"Body_part"}],"attributes":[{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma7195"},{"id":"A6","pred":"fma_id","subj":"T6","obj":"http://purl.org/sig/ont/fma/fma9576"}],"text":" admission, resolution with treatment\n• lll-defined peripheral GGO, usually subpleural • Leukopenia (2/3)\n• Lymphopenia (2/3)\n• CXR: Bilateral interstitial infiltrates • Abnormal CXR (59% on admission, 98% anytime)\n• 63% patients – first unifocal infiltrates at 4.5 ± 2.1 days\n• 37% patients - started as multifocal infiltrates at 5.8 ± 1.3 days after fever onset Initial CXR abnormal: 71%• One lung zone: 49%\n• Multizonal: 21%\nChest CT abnormal (55% of 33)• One lobe: 55%\n• Multilobar: 46%\n• Focal ground-glass opacificat"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T10","span":{"begin":395,"end":399},"obj":"Body_part"},{"id":"T11","span":{"begin":428,"end":433},"obj":"Body_part"},{"id":"T12","span":{"begin":463,"end":467},"obj":"Body_part"}],"attributes":[{"id":"A10","pred":"uberon_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"A11","pred":"uberon_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/UBERON_0001443"},{"id":"A12","pred":"uberon_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/UBERON_3010752"}],"text":" admission, resolution with treatment\n• lll-defined peripheral GGO, usually subpleural • Leukopenia (2/3)\n• Lymphopenia (2/3)\n• CXR: Bilateral interstitial infiltrates • Abnormal CXR (59% on admission, 98% anytime)\n• 63% patients – first unifocal infiltrates at 4.5 ± 2.1 days\n• 37% patients - started as multifocal infiltrates at 5.8 ± 1.3 days after fever onset Initial CXR abnormal: 71%• One lung zone: 49%\n• Multizonal: 21%\nChest CT abnormal (55% of 33)• One lobe: 55%\n• Multilobar: 46%\n• Focal ground-glass opacificat"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T37","span":{"begin":89,"end":99},"obj":"Disease"},{"id":"T38","span":{"begin":108,"end":119},"obj":"Disease"}],"attributes":[{"id":"A37","pred":"mondo_id","subj":"T37","obj":"http://purl.obolibrary.org/obo/MONDO_0003785"},{"id":"A38","pred":"mondo_id","subj":"T38","obj":"http://purl.obolibrary.org/obo/MONDO_0003783"}],"text":" admission, resolution with treatment\n• lll-defined peripheral GGO, usually subpleural • Leukopenia (2/3)\n• Lymphopenia (2/3)\n• CXR: Bilateral interstitial infiltrates • Abnormal CXR (59% on admission, 98% anytime)\n• 63% patients – first unifocal infiltrates at 4.5 ± 2.1 days\n• 37% patients - started as multifocal infiltrates at 5.8 ± 1.3 days after fever onset Initial CXR abnormal: 71%• One lung zone: 49%\n• Multizonal: 21%\nChest CT abnormal (55% of 33)• One lobe: 55%\n• Multilobar: 46%\n• Focal ground-glass opacificat"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T22","span":{"begin":386,"end":388},"obj":"http://purl.obolibrary.org/obo/CLO_0054055"},{"id":"T23","span":{"begin":395,"end":399},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T24","span":{"begin":395,"end":399},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"},{"id":"T25","span":{"begin":428,"end":433},"obj":"http://www.ebi.ac.uk/efo/EFO_0000965"}],"text":" admission, resolution with treatment\n• lll-defined peripheral GGO, usually subpleural • Leukopenia (2/3)\n• Lymphopenia (2/3)\n• CXR: Bilateral interstitial infiltrates • Abnormal CXR (59% on admission, 98% anytime)\n• 63% patients – first unifocal infiltrates at 4.5 ± 2.1 days\n• 37% patients - started as multifocal infiltrates at 5.8 ± 1.3 days after fever onset Initial CXR abnormal: 71%• One lung zone: 49%\n• Multizonal: 21%\nChest CT abnormal (55% of 33)• One lobe: 55%\n• Multilobar: 46%\n• Focal ground-glass opacificat"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T27","span":{"begin":89,"end":99},"obj":"Phenotype"},{"id":"T28","span":{"begin":108,"end":119},"obj":"Phenotype"},{"id":"T29","span":{"begin":352,"end":357},"obj":"Phenotype"}],"attributes":[{"id":"A27","pred":"hp_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/HP_0001882"},{"id":"A28","pred":"hp_id","subj":"T28","obj":"http://purl.obolibrary.org/obo/HP_0001888"},{"id":"A29","pred":"hp_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/HP_0001945"}],"text":" admission, resolution with treatment\n• lll-defined peripheral GGO, usually subpleural • Leukopenia (2/3)\n• Lymphopenia (2/3)\n• CXR: Bilateral interstitial infiltrates • Abnormal CXR (59% on admission, 98% anytime)\n• 63% patients – first unifocal infiltrates at 4.5 ± 2.1 days\n• 37% patients - started as multifocal infiltrates at 5.8 ± 1.3 days after fever onset Initial CXR abnormal: 71%• One lung zone: 49%\n• Multizonal: 21%\nChest CT abnormal (55% of 33)• One lobe: 55%\n• Multilobar: 46%\n• Focal ground-glass opacificat"}

{"project":"LitCovid-sentences","denotations":[{"id":"T52","span":{"begin":38,"end":105},"obj":"Sentence"},{"id":"T53","span":{"begin":106,"end":125},"obj":"Sentence"},{"id":"T54","span":{"begin":126,"end":132},"obj":"Sentence"},{"id":"T55","span":{"begin":133,"end":214},"obj":"Sentence"},{"id":"T56","span":{"begin":215,"end":276},"obj":"Sentence"},{"id":"T57","span":{"begin":277,"end":385},"obj":"Sentence"},{"id":"T58","span":{"begin":386,"end":405},"obj":"Sentence"},{"id":"T59","span":{"begin":406,"end":409},"obj":"Sentence"},{"id":"T60","span":{"begin":410,"end":423},"obj":"Sentence"},{"id":"T61","span":{"begin":424,"end":427},"obj":"Sentence"},{"id":"T62","span":{"begin":428,"end":468},"obj":"Sentence"},{"id":"T63","span":{"begin":469,"end":472},"obj":"Sentence"},{"id":"T64","span":{"begin":473,"end":486},"obj":"Sentence"},{"id":"T65","span":{"begin":487,"end":490},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" admission, resolution with treatment\n• lll-defined peripheral GGO, usually subpleural • Leukopenia (2/3)\n• Lymphopenia (2/3)\n• CXR: Bilateral interstitial infiltrates • Abnormal CXR (59% on admission, 98% anytime)\n• 63% patients – first unifocal infiltrates at 4.5 ± 2.1 days\n• 37% patients - started as multifocal infiltrates at 5.8 ± 1.3 days after fever onset Initial CXR abnormal: 71%• One lung zone: 49%\n• Multizonal: 21%\nChest CT abnormal (55% of 33)• One lobe: 55%\n• Multilobar: 46%\n• Focal ground-glass opacificat"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T68","span":{"begin":143,"end":155},"obj":"UBERON:0005169"},{"id":"T69","span":{"begin":395,"end":399},"obj":"UBERON:0002048"},{"id":"T70","span":{"begin":463,"end":467},"obj":"UBERON:3010752"},{"id":"T475","span":{"begin":56,"end":61},"obj":"UBERON:0000178"},{"id":"T476","span":{"begin":76,"end":81},"obj":"UBERON:0000948"},{"id":"T477","span":{"begin":104,"end":109},"obj":"UBERON:0000948"},{"id":"T478","span":{"begin":162,"end":172},"obj":"UBERON:0002349"},{"id":"T479","span":{"begin":184,"end":189},"obj":"UBERON:0001443"},{"id":"T480","span":{"begin":227,"end":238},"obj":"GO:0015671"},{"id":"T481","span":{"begin":287,"end":294},"obj":"CHEBI:24996;CHEBI:24996"},{"id":"T482","span":{"begin":311,"end":315},"obj":"UBERON:0002084"},{"id":"T483","span":{"begin":317,"end":342},"obj":"UBERON:0002084"},{"id":"T484","span":{"begin":357,"end":367},"obj":"UBERON:0002349"},{"id":"T485","span":{"begin":380,"end":388},"obj":"SP_9"},{"id":"T486","span":{"begin":390,"end":401},"obj":"SP_9"},{"id":"T487","span":{"begin":402,"end":412},"obj":"SP_9;UBERON:0001004;GO:0045333"},{"id":"T488","span":{"begin":414,"end":434},"obj":"SP_9"},{"id":"T489","span":{"begin":469,"end":478},"obj":"SP_10"},{"id":"T490","span":{"begin":480,"end":492},"obj":"SP_10"},{"id":"T491","span":{"begin":493,"end":503},"obj":"SP_10;UBERON:0001004"}],"text":" admission, resolution with treatment\n• lll-defined peripheral GGO, usually subpleural • Leukopenia (2/3)\n• Lymphopenia (2/3)\n• CXR: Bilateral interstitial infiltrates • Abnormal CXR (59% on admission, 98% anytime)\n• 63% patients – first unifocal infiltrates at 4.5 ± 2.1 days\n• 37% patients - started as multifocal infiltrates at 5.8 ± 1.3 days after fever onset Initial CXR abnormal: 71%• One lung zone: 49%\n• Multizonal: 21%\nChest CT abnormal (55% of 33)• One lobe: 55%\n• Multilobar: 46%\n• Focal ground-glass opacificat"}